Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Warsaw - Delayed Quote PLN

Ryvu Therapeutics S.A. (RVU.WA)

32.95
-1.00
(-2.95%)
At close: April 29 at 5:03:11 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 25.03M
Earnings -26.57M

Q4'23

Q1'24

Q2'24

Q3'24

-30M
-20M
-10M
0
10M
20M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

33.50
50.58 Average
32.95 Current
80.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----33
Avg. Estimate 00-5.05-5.03
Low Estimate 00-7.58-9.17
High Estimate 00-3.3-2.9
Year Ago EPS -----4.8-5.05

Revenue Estimate

Currency in PLN Current Qtr. (Mar 2025)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts 2--44
Avg. Estimate 20.55M--124.92M155.5M
Low Estimate 19.6M--78.4M49.3M
High Estimate 21.5M--168.5M202M
Year Ago Sales 25.43M--101.96M124.92M
Sales Growth (year/est) -19.18%--22.52%24.47%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Current Estimate 00-5.05-5.03
7 Days Ago 00-5.44-6.03
30 Days Ago 00-5.44-6.03
60 Days Ago 00-3.3-2.9
90 Days Ago 00-3.4-4.6

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
RVU.WA -----5.28%0.40%
S&P 500 9.62%4.20%8.36%13.90%